BRAF V600E mutation status detection facilitates prognosis prediction in papillary thyroid carcinoma (PTC). We developed a deep-learning model to determine the BRAF V600E status in PTC. PTC from three centers were collected as the training set (1341 patients), validation set (148 patients), and external test set (135 patients). After testing the performance of the ResNeSt-50, Vision Transformer, and Swin Transformer V2 (SwinT) models, SwinT was chosen as the optimal backbone. An integrated BrafSwinT model was developed by combining the backbone with a radiomics feature branch and a clinical parameter branch. BrafSwinT demonstrated an AUC of 0.869 in the external test set, outperforming the original SwinT, Vision Transformer, and ResNeSt-50 models (AUC: 0.782-0.824; p value: 0.017-0.041). BrafSwinT showed promising results in determining BRAF V600E mutation status in PTC based on routinely acquired ultrasound images and basic clinical information, thus facilitating risk stratification.